James M Daly is Director of CYTOKINETICS INC. Currently has a direct ownership of 197 shares of CYTK, which is worth approximately $13,088. The most recent transaction as insider was on Jan 15, 2026, when has been sold 197 shares (Common Stock) at a price of $63.44 per share, resulting in proceeds of $12,497. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 197
n/a 3M change
n/a 12M change
Total Value Held $13,088

James M Daly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2026
BUY
Grant, award, or other acquisition
$12,497 $63.44 p/Share
197 Added 50.0%
197 Common Stock

Also insider at

HALO
HALOZYME THERAPEUTICS, INC. Healthcare
BLCM
BELLICUM PHARMACEUTICALS, INC Healthcare
MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
JMD

James M Daly

Director
Houston, TX

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK